Log in or Sign up for Free to view tailored content for your specialty!
Spondyloarthropathies News
Virtual exercise classes safe, effective in patients with musculoskeletal disease
Hour-long, virtual exercise classes that cover Pilates, yoga and tai chi are safe and improved health outcomes in patients with musculoskeletal disease, according to data presented at ACR Convergence 2021.
JUNIPERA: Secukinumab reduces flare risk in juvenile PsA, enthesitis-related arthritis
Secukinumab is efficacious in children and adolescents with psoriatic arthritis and enthesitis-related arthritis, resulting in a significantly longer time to flare versus placebo, according to data presented at ACR Convergence 2021.
Log in or Sign up for Free to view tailored content for your specialty!
Axial PsA therapies fall short of axial SpA surplus due to absent classification criteria
While there is a cross-section of drugs that are FDA-approved for the treatment of axial spondyloarthritis, clinicians and researchers continue to struggle with axial psoriatic arthritis, according to a presenter at ACR Convergence 2021.
Artificial neural network accurately detects sacroiliitis in suspected axial SpA
A newly developed artificial neural network can accurately detect radiographic sacroiliitis in patients with suspected axial spondyloarthritis, according to data presented at ACR Convergence 2021.
Maintenance infliximab more effective with therapeutic drug monitoring
Therapeutic drug monitoring, in which serum levels are regularly checked to adjust dose and intervals, is more effective at controlling disease than standard therapy with infliximab, according to data presented at ACR Convergence 2021.
B-cell therapies, mycophenolate worsen COVID-19 vaccine response in inflammatory disease
Patients with chronic inflammatory disease on immunosuppressants, especially B-cell depleting agents, mycophenolate and glucocorticoids, exhibited poor antibody responses to the mRNA vaccine for COVID-19, according to a presenter here.
FDA approves Cortrophin Gel for rheumatoid arthritis, multiple sclerosis
The FDA has approved a supplemental new drug application for ANI Pharmaceutical’s Cortrophin Gel to treat rheumatoid arthritis, multiple sclerosis and certain other autoimmune diseases, according to a company press release.
Physical activity may improve quality of life, self-reported function in RA, PsA, SpA
Physical activity can lead to improved quality of life and self-reported function in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis, according to data published in Arthritis Care & Research.
Treat-to-target TNF-inhibitor tapering does not negatively impact PsA, axial SpA activity
Treat-to-target tapering of TNF inhibitors in patients with psoriatic arthritis or axial spondyloarthritis does not result in any negative impact on disease activity, compared with the full dose, according to data published in Rheumatology.
CARE referral rule bests REACH for detecting inflammatory arthritis, rheumatic disease
Compared to the Rotterdam Early Arthritis Cohort referral rule, the Clinical Arthritis Rule had superior specificity and overall diagnostic performance in recognizing inflammatory arthritis and inflammatory rheumatic disease in primary care.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read